Perfil
Michael R.
Slater held several positions in the pharmaceutical industry, starting as a Senior Manager-Medical Services at Hoechst Pharmaceuticals Ltd.
from 1971 to 1983.
He then worked at Biogen SA as Director-Corporate Regulatory Affairs from 1983 to 1985, and at Biogen MA, Inc. as Vice President-Regulatory Affairs from 1985 to 1995.
He was Executive Vice President-Development Operations at ImmuLogic Pharmaceutical Corp.
from 1995 to 1996, and Vice President-Operations at Anika Therapeutics, Inc. from 1998 to 2001.
He later worked at Merrimack Pharmaceuticals, Inc. as Head-Regulatory Affairs from 2010 to 2019, and at Synlogic, Inc. as Head-Regulatory Affairs from 2019 to 2021.
Slater received his undergraduate degree from Leeds Beckett University.
Antiguos cargos conocidos de Michael R. Slater.
| Empresas | Cargo | Fin |
|---|---|---|
| SYNLOGIC, INC. | Consejero General | 01/06/2021 |
| MERRIMACK PHARMACEUTICALS, INC. | Consejero General | 01/01/2019 |
| ANIKA THERAPEUTICS, INC. | Director de Operaciones | 01/01/2001 |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Corporate Officer/Principal | 01/01/1996 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Consejero General | 01/01/1995 |
Formación de Michael R. Slater.
| Leeds Beckett University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| ACUSPHERE, INC. | Health Technology |
| SYNLOGIC, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Hoechst Pharmaceuticals Ltd. | |
| Biogen SA |
- Bolsa de valores
- Insiders
- Michael R. Slater
